Efficacy of mRNA vaccines on SARS-CoV-2 variants (UK and South Africa) Detection of mutations arising in the genome of the SARS-CoV-2 virus responsible for COVID-19 have led to concerns that new forms of the virus might enable it to evade the protection conferred by recently approved mRNA vaccines. Two strains in particular, B.1.1.7 from England […]
Efficacy of mRNA vaccines on SARS-CoV-2 variants (UK and South Africa) Detection of mutations arising in the genome of the SARS-CoV-2 virus responsible for COVID-19 have led to concerns that
Potential Multiple Sclerosis mRNA Vaccine BioNTech in Germany is one of two companies (the other being Moderna in the US) that have successfully developed mRNA vaccines against SARS-CoV-2, the virus
